Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Dosing for treatment with anti-CD20/anti-CD3 bispecific antibodies

Dosing for treatment with anti-CD20/anti-CD3 bispecific antibodies

US Patent 11466094 · Granted Oct 11, 2022

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Subcutaneous dosing of anti-CD20/anti-CD3 bispecific antibodies2025
Dosing for treatment with anti-CD20/anti-CD3 bispecific antibodies2025
Anti-C-C motif chemokine receptor 8 (CCR8) antibodies and methods of use2025
Methods of using anti-CD79b immunoconjugates2024
Anti-tryptase antibodies, compositions thereof, and uses thereof2024
FLT3 ligand fusion proteins and methods of use2023
Methods of using anti-CD79b immunoconjugates2021
Anti-tryptase antibodies, compositions thereof, and uses thereof2020
Anti-tryptase antibodies, compositions thereof, and uses thereof2020
Dispersions of microemulsions in hydrogels for drug delivery2011